Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Impact of a Reinforced Graphene Oxide and Alginate Hydrogel with an Oxygen Releasing System on the Biocompatibility of Pancreatic β-Cells for Diabetes Therapy.

Created on 23 Jul 2026

Authors

Elías Cuartas-Gómez, Oscar Vargas-Ceballos, Natalia Moreno-Castellanos

Published in

Macromolecular bioscience. Volume 26. Issue 7. Pages e70227.

Abstract

Type 1 diabetes is characterized by autoimmune destruction of pancreatic β-cells, resulting in insulin deficiency and impaired blood glucose regulation. Cell encapsulation using alginate-based hydrogels offers immunoprotection but faces challenges due to low oxygen solubility, compromising cell survival to restore vascularization after implantation. To address this, we developed an alginate hydrogel reinforced with graphene oxide (ALGO) and integrated calcium peroxide (CPO) as an oxygen-releasing system, stabilized with poly-L-lysine (PLL). Physicochemical and mechanical characterization confirmed incorporation of all components and improved elasticity with increasing CPO concentration. Hydrogels maintained structural stability for eight days and released oxygen throughout this period. Biocompatibility assays revealed that ALGO containing 0.25% CPO (0.25CPO) preserved cell viability and proliferation for 96 h, while 1% CPO negatively affected survival. Oxygen consumption analysis showed that 0.25CPO sustained mitochondrial respiration and enhanced maximal respiratory capacity. Glucose-stimulated insulin secretion demonstrated that 0.25CPO maintained functional responsiveness under low and high glucose conditions. These findings indicate that 0.25CPO hydrogels provide controlled oxygen delivery, mechanical stability, and improved biocompatibility, making them a promising platform for pancreatic β-cell encapsulation and future preclinical applications in type 1 diabetes therapy.

PMID:
42490035
Bibliographic data and abstract were imported from PubMed on 23 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement